Core Viewpoint - Zhongwei New Materials Co., Ltd. has completed the registration and amendment procedures following its H-share issuance, increasing its registered capital from 938 million yuan to 1.042 billion yuan, with total shares exceeding 1 billion [1][2]. Group 1 - The company has successfully listed its H-shares on the Hong Kong Stock Exchange, issuing 104,225,400 shares [1][2]. - The total number of shares has increased from 938,028,458 to 1,042,253,858, reflecting the completion of the H-share issuance [2]. - The company's core information, including its name, legal representative, and registered address, remains unchanged, with the legal representative being Deng Weiming [2]. Group 2 - The issuance is expected to optimize the company's capital structure and enhance its international operational capabilities [2]. - The updated company articles have been disclosed on the designated information disclosure website [2].

Core Viewpoint - The company has set the final price for its H-share issuance at HKD 22 per share, excluding various transaction fees [1] Group 1 - The H-share issuance is expected to be listed and commence trading on the Hong Kong Stock Exchange on November 6, 2025 [1] - The issuance price does not include a 1% brokerage commission, a 0.0027% transaction fee from the Hong Kong Securities and Futures Commission, a 0.00565% trading fee from the Hong Kong Stock Exchange, and a 0.00015% transaction fee from the Hong Kong Institute of Certified Public Accountants [1]

Core Viewpoint - The company, Junsheng Electronics, is set to launch a global offering of H-shares, with a total of 155 million shares available for issuance, subject to adjustments based on demand and over-allotment options [1] Group 1: Offering Details - The base number of H-shares for the global offering is 155 million shares, with 15.51 million shares allocated for public offering in Hong Kong, representing 10% of the total offering [1] - The international offering will consist of 140 million shares, accounting for 90% of the total offering [1] - In the event that the over-allotment option is fully exercised, the maximum number of H-shares to be issued will increase to 205 million shares [1] Group 2: Pricing and Timeline - The maximum price for the H-shares is set at HKD 23.60 [1] - The public offering in Hong Kong will commence on October 28, 2025, and is expected to conclude by November 3, 2025 [1] - The final issuance price is anticipated to be announced by November 5, 2025 [1]

Core Viewpoint - The company Huaheng Biological (688639.SH) has submitted an application for issuing H-shares and listing on the main board of the Hong Kong Stock Exchange as of September 30, 2025 [1] Group 1 - The company has filed the application with the Hong Kong Stock Exchange and published the relevant application materials on the exchange's website [1] - The company has also submitted the filing application materials to the China Securities Regulatory Commission (CSRC), which has recently accepted the application [1]

Core Viewpoint - Guanghetong (300638) announced a global offering of H-shares, with a total of 135 million shares to be issued, subject to the exercise of the over-allotment option [1] Summary by Sections Global Offering Details - The total number of H-shares for global issuance is 135 million, with 13.5082 million shares allocated for public offering in Hong Kong, accounting for approximately 10% of the total [1] - The international offering will consist of 122 million H-shares, representing about 90% of the total offering [1] - In the event of full exercise of the over-allotment option, the maximum number of H-shares to be issued will increase to 155 million [1] Pricing and Timeline - The price range for the H-share issuance is preliminarily set between HKD 19.88 and HKD 21.50 [1] - The Hong Kong public offering is scheduled to commence on October 14, 2025, and is expected to conclude on October 17, 2025 [1] - The issuance price is anticipated to be announced by October 21, 2025, inclusive of that date [1]

Core Viewpoint - The company plans to issue H-shares and apply for listing on the Hong Kong Stock Exchange, with the board's approval obtained on July 25, 2025 [1] Group 1 - The company has received preliminary approval from the Beijing State-owned Assets Supervision and Administration Commission for the overall plan of the public issuance of H-shares [1] - The issuance is subject to approval from the shareholders' meeting and requires further approvals or filings from relevant government and regulatory agencies [1]

Core Viewpoint - The company has received approval from the Shanghai State-owned Assets Supervision and Administration Commission for its H-share issuance plan, which is a significant step towards expanding its capital base and enhancing its market presence [1] Group 1: H-Share Issuance - The company plans to issue H-shares not exceeding 15% of its total share capital post-issuance [1] - An over-allotment option of up to 15% of the H-share issuance is granted [1] - The issuance is subject to approval from the company's shareholders and requires regulatory approvals from various government and regulatory bodies [1]

Core Viewpoint - The company plans to issue H-shares and list them on the Hong Kong Stock Exchange to enhance its global brand recognition, optimize capital structure, and expand financing channels [5][10][11]. Proposal Summaries - Proposal 1: Issuance of H-shares and listing on the Hong Kong Stock Exchange [1][4]. - Proposal 2: Plan for the issuance of H-shares [1][4]. - Proposal 3: Use of funds raised from the H-share issuance [1][10]. - Proposal 4: Application to convert to an overseas fundraising company [1][10]. - Proposal 5: Profit distribution plan before H-share issuance [1][10]. - Proposal 6: Proposal to cancel the supervisory board [1][12]. - Proposal 7: Amendments to the company's articles of association and related rules [1][12]. - Proposal 8: Draft amendments to the articles of association applicable after H-share issuance [1][14]. - Proposal 9: Amendments to internal governance systems applicable after H-share issuance [1][14]. - Proposal 10: Appointment of auditing firm for H-share issuance and listing [1][16]. - Proposal 11: Addition of directors [1][17]. - Proposal 12: Determination of director roles and members of the board committees [1][18]. - Proposal 13: Purchase of liability insurance for directors and senior management [1][18]. - Proposal 14: Authorization for the board to handle matters related to H-share issuance and listing [1][19]. Meeting Procedures - The meeting will be conducted with a combination of on-site and online voting [4][5]. - Attendees must register and confirm their participation before the meeting starts [2][3]. - Shareholders have the right to speak, inquire, and vote during the meeting [2][3]. Fundraising and Use of Proceeds - The funds raised will be used for international business expansion, product development, and general operational needs [10][11]. - The issuance will not exceed 15% of the total share capital post-issuance, with an option for over-allotment [6][7]. Governance Changes - The supervisory board will be abolished, with its functions transferred to the audit committee of the board [12][13]. - The board will increase its members from 6 to 8, with adjustments to the roles of non-executive and independent directors [17][18]. Compliance and Legal Framework - The issuance will comply with relevant laws and regulations, including those from the China Securities Regulatory Commission and the Hong Kong Stock Exchange [10][11][19]. - The company will appoint Ernst & Young as the auditing firm for the H-share issuance [16].

Core Viewpoint - The company plans to privatize New Horizon Energy Holdings Limited through its wholly-owned subsidiary, New Energy (Hong Kong) Investment Co., Ltd., and will issue H shares to the shareholders of New Horizon Energy as part of the transaction [1]. Group 1: Audit Firm Appointment - The company has proposed to appoint Guowei Certified Public Accountants as the auditing firm for the H share issuance, based on their extensive experience in financial audits for H share listings [2]. - Guowei Certified Public Accountants was established in 1983 and currently serves approximately 85 listed companies, with expertise in various industries including real estate, securities investment, and pharmaceuticals [2]. - The appointment of the auditing firm requires approval from the company's shareholders' meeting [3]. Group 2: Meeting Procedures - The company held multiple meetings on May 14 and May 16, 2025, where the board and supervisory committee approved the proposal to hire Guowei Certified Public Accountants for the H share issuance [3]. - The decision to appoint the auditing firm will take effect upon approval by the shareholders' meeting [3].